FLGT Q4 2021 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q4 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$252M-14.7% YoY

Gross Profit

$190M75.3% margin

Operating Income

$151M59.9% margin

Net Income

$104M41.5% margin

EPS (Diluted)

$3.34

QoQ Revenue Growth

+10.4%

Cash Flow

Operating Cash Flow

$77M

Free Cash Flow

$71M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$113M

Stockholders' Equity

$1.2B

Cash & Equivalents

$165M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$252M	$295M	-14.7%
Gross Profit	$190M	$243M	-22.1%
Operating Income	$151M	$226M	-33.2%
Net Income	$104M	$166M	-37.3%

Geographic Segments

UNITED STATES

$248M98%

Non Us

$4M2%